Diagnostic technology for COVID-19: comparative evaluation of antigen and serology-based SARS-CoV-2 immunoassays, and contact tracing solutions for potential use as at-home products

Mehdi Jorfi, Nell Meosky Luo, Aditi Hazra, Fanny Herisson, Glenn Miller, James A. Toombs, David R. Walt, Paolo Bonato, Rushdy Ahmad, COVID-19 Direct-to-Consumer Task Force Investigators
doi: https://doi.org/10.1101/2020.06.25.20140236

Data Availability

The datasets generated during and/or analyzed during the current study are available at the Mass General Brigham Center for COVID Innovation (MGB-CCI) website.

https://covidinnovation.partners.org/diagnostics-direct-to-consumer/

Back to top
Posted June 29, 2020.
Download PDF
Data/Code
Email
Diagnostic technology for COVID-19: comparative evaluation of antigen and serology-based SARS-CoV-2 immunoassays, and contact tracing solutions for potential use as at-home products
Mehdi Jorfi, Nell Meosky Luo, Aditi Hazra, Fanny Herisson, Glenn Miller, James A. Toombs, David R. Walt, Paolo Bonato, Rushdy Ahmad, COVID-19 Direct-to-Consumer Task Force Investigators
medRxiv 2020.06.25.20140236; doi: https://doi.org/10.1101/2020.06.25.20140236
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area